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It  has  been clearly established  that  B  lymphocytes, like other components of the 
hematopoietic system, arise from muhipotential  stem cells  (1-3).  In the mouse, stem 
cells are first detected in the yolk sac of 7-d-old fetuses (4).  Subsequently, they migrate 
into the embryo and by day 10-12 have given rise to progeny, found in the fetal liver, 
capable  of synthesizing  immunoglobulin  (5-7).  Typically,  these  cells  are  large  and 
contain  detectable  levels  of cytoplasmic  immunoglobulin  (cIg), 1 but  do  not  stably 
display surface immunoglobulin  (sIg)  (5-7). They are designated  pre-B cells as they 
are thought to be the direct  progenitors of smaller sIg  + B cells which first  appear in 
16- to 17-d-old embryos (5-12). A similar cIg+sIg  -  celt has also been detected in adult 
bone  marrow,  the  primary  site  of hematopoiesis  in  mature  mice  and  may  be  an 
analogous intermediate  along the stem cell to B-cell pathway  (6,  13-15). 
Although  this  framework  for B-cell  differentiation  currently  represents  the  most 
plausible interpretation of available data, it is neither complete nor necessarily correct. 
The factors which influence the transition  of a stem cell into the B lineage,  and even 
the  site(s)  of commitment,  remain  obscure.  Furthermore,  while  it  is  tempting  to 
assume that B-cell development in adult mice proceeds in a  manner identical to fetal 
differentiation,  this has not yet been established. 
The present  study was undertaken  to evaluate the differentiative and proliferative 
potential of various B-cell precursors present tduring fetal and adult life. We monitored 
the emergence of B  lymphocytes from progenitors found in yolk sac, fetal  liver, and 
adult organs after injection into unirradiated or irradiated  immunodeficient CBA/N 
recipients.  The impetus  for these studies was the discovery that  CBA/N mice lack a 
class  of B  cells  capable  of forming  colonies  in  agar,  yet,  nonetheless,  provide  an 
environment  suitable  for their  development  from less  differentiated  cells  of normal 
donors (16,  17).  Among the advantages of this protocol are:  (a)  It detects a  functional 
B  cell  which  is  present  in  all  populations  of B  lymphocytes  except  those  in  the 
CBA/N  mouse;  (b)  small  numbers  of cells  are  easily  monitored  owing to both  the 
sensitivity of the B-cell cloning assay and to the background-free environment of the 
CBA/N  host;  (c)  colony formation  is  not  dependent  on accessory cells  and  is  linear 
under  the  conditions  employed;  and  (d)  use  of CBA/H-T6T6  cells  enables  us  to 
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compare  B-cell  reconstitution  with  reconstitution  of  other  cell  compartments  by 
cytogenic analysis  ( 16-18). 
Materials  and  Methods 
Mice.  The  mice used  in these studies were all from our own colony and  maintained  in a 
laminar  flow air-supplied  room  under  specific pathogen-free  conditions.  CBA/N mice were 
originally obtained  from  the  National  Institutes  of Health  (NIH),  Bethesda,  Md.,  CBA/H- 
T6T6  from  Dr.  O.  Stutman,  Sloan-Kettering  Institute,  N.  Y.,  and  CBA/Cum  mice  were 
purchased  from Cumberland View Farms, Clinton, Tenn. 
Irradiation.  Mice were exposed to variable amounts of radiation  emitted from a  137Cesium 
irradiator delivered at a dose rate of 113.5 rads/min (J. L. Shepherd, Glendale, Calif.). In most 
experiments  mice  received  either  a  single  dose  of  1,050  rads  or  a  split  dose  of  1,300  rads 
delivered in equal parts 3.5 h apart. 
Preparation of Cell Suspensions from  Fetal and Adult  Mice.  Female CBA/H-T6T6  mice were 
housed together with males and examined each morning for the presence of vaginal plugs. The 
day of appearance  of a  plug was designated  day 0  and  pregnant  mice were sacrificed 9-14 d 
later. The uteri were removed, washed with medium and cleaned of all maternal  blood. The 
embryos, along with the placenta and the surrounding endometrium, were removed by carefully 
cutting away the uterine  membrane with fine scissors. These were again extensively rinsed to 
remove more maternal blood and the embryos, with yolk sac intact, were freed from surrounding 
tissue.  After another washing  the yolk sacs were separated  from the embryos  and  allowed to 
settle through  4-5 ml of medium containing 5% fetal calf serum  (FCS). Single cell suspensions 
of yolk sacs were prepared  by gently drawing the tissue through  a  26-gauge needle. After the 
cells were expelled, clumps were allowed to settle, single cells in the supernate were harvested, 
and viable cell counts were obtained using trypan blue. In older embryos,  12-14 d of gestation, 
livers  were  removed  using  fine  needles,  washed  extensively,  partially  minced,  and  drawn 
through a  26-gauge needle. Single cell suspensions of either fetal liver or yolk sac were injected 
intravenously; when large numbers of cells were injected, heparin was added at a concentration 
of 5 U/ml. For yolk sac experiments,  10-20 pregnant mice in the 9th or 10th day of pregnancy 
were sacrificed, each yielding 6  9  embryos.  Fetal  liver was usually obtained  from  3-10  mice 
12-14 d  pregnant. 
Single cell suspensions of adult spleen or mesenteric lymph node were prepared  by pushing 
partially minced tissue through a fine wire screen. Femoral bone marrow cells were obtained by 
flushing them out with  1 ml of medium. Clumps were dispersed by gentle passage  through  a 
26-gauge needle. Viable nucleated cell counts were obtained in the presence of trypan blue. 
B-cell Cloning Assay.  B-cell cloning in soft agar was performed as described previously (18, 
19). Single cell suspensions were plated with 1 ml of McCoy's medium (Grand Island Biological 
Co.,  [GIBCO], Grand  Island,  N.  Y.), containing  15%  fcs  (Flow Laboratories,  Inc.,  Rockville, 
Md.), 0.3% agar (Difco Laboratories, Detroit, Mich.) and supplemented as previously described 
(18) at concentrations which varied from 2.5  10 ×  10~/ml. The cultures were usually stimulated 
with either 10 pg lipopolysaccharide (LPS)  (Salmonella typhosa W0901, Difco Laboratories) alone 
or with LPS  +  0.05 ml of 20% sheep erythrocytes (SRBC)  (Flow), which had been previously 
washed 5 times in 5 vol of phosphate-buffered saline (PBS). After the cultures had gelled, they 
were  placed  at  37°C  in  a  humid  atmosphere  containing  7%  CO2  for 6  d.  The cultures  were 
examined under a  dissecting microscope and the number of colonies consisting of 20 or more 
cells was  determined.  Cultures  containing  SRBC  were  fixed  in  0.3%  acetic  acid  to  lyse the 
erythrocytes which otherwise obscure B-cell colonies. 
Chromosome analysis.  Chromosome analysis was done with single cell suspensions of spleen or 
bone marrow cultured in the presence of either LPS, phytohemagglutinin  (PHA), concanavalin 
A  (Con A), or colony-stimulating activity (CSA). For the analysis of lymphoid cells, host spleen 
was  cultured  at  a  concentration  of 2  ×  10~/ml  in  RPMI  +  5%  FCS at  37°C  in  a  humid 
atmosphere  which  contained  7%  CO2  for  3  d  in  the  presence  of either  I0  /~g  LPS  (+  2- 
mercaptoethanol),  10 pg PHA, or  10/Lg Con A. For the analysis of granulocyte-macrophage 
progenitors,  spleen or bone marrow  cells were cultured  in McCoy's medium  containing  15% 
FCS and supplemented as described previously for B-cell cloning (without 2-mercaptoethanol), 
at  a  concentration of 2  ×  105/ml in the presence of 0.1  ml/ml of 10-times-concentrated  CSA 550  B LYMPHOCYTE  PRECURSORS 
obtained from the supernate of the WEHI-3 cell line. Liquid cultures were pulsed on the third 
day of culture with colcemid (0.2 pg/ml) 90 min before harvesting. The cells were spun down 
and resuspended in  1 ml of 0.95%  sodium citrate and allowed to swell for 20 min.  1 ml of 
fixative, consisting of three parts ethanol and one part acetic acid, was layered over the cells, 
allowed to stand for 5 min, and then gently mixed with a  Pasteur pipette. After 15 min, the 
cells were gently spun down and resuspended in 100% fixative. After an additional 15 min, the 
cells were again centrifuged and resuspended in one or two drops of 45% acetic acid. This was 
placed on a warm glass slide and allowed to slowly dry while manually spreading the cells over 
the surface of the slide by gentle rocking. Splenic foci, obtained 9 d after injection of 2.5  ×  104 
bone  marrow  cells into  an  irradiated syngeneic mouse,  were  also chromosome  typed.  The 
splenic foci were carefully removed with a scalpel and nonfoci area was trimmed away. A single 
cell suspension was made in RPMI by gently teasing the foci apart wiih two 26-gauge needles, 
and the cultures were then pulsed with colcemid for 90 rain and prepared as described above. 
Alternatively, 50/xg of colcemid was injected i.p. 90 rain before sacrifice and removal of spleen 
foci.  In either case  10-50  metaphases were examined to determine the chromosome type of 
each focus. 
B-cell Depletion.  B  lymphocyte-depleted bone  marrow  was  obtained  with  two  protocols. 
Treatment with anti-/~ antibodies was initiated on the day of birth (0.5 mg/mouse injected i.p.) 
and repeated daily for 4 d, after which weekly injections were continued for 4 wk. Bone marrow 
was  used  2  d  after  the  final  injection.  In  the  second  procedure,  bone  marrow  cells were 
incubated at a concentration of 10  ×  106/ml for 70 min at 4°C in 100  ×  15-mm polystyrene 
Petri  dishes  (Falcon Labware,  Div.  of Becton,  Dickinson & Co.,  Oxnard,  Calif.)  previously 
coated with anti-IgM antibodies. 
Results 
Absence of Clonable B Cells in Fetal and Adult CBA/N Mice.  B lymphocytes capable of 
forming colonies in semisolid agar (CFU-B) are first detected in the liver and spleen 
of normal  16.5-d embryos and subsequently are present among all B-cell populations 
(18,  19, 22-24). Furthermore, the cloning efficiency of sIg  + B cells in normal newborn 
spleen, adult  bone  marrow,  spleen, lymph  nodes,  and  peripheral blood was  similar 
when  LPS was used  to potentiate the cultures  (18).  Immunodeficient  CBA/N  mice 
are exceptional in lacking B  cells which function in this assay (16). As demonstrated 
in Table I, these are not  detectable in CBA/N  tissues at  any stage of development. 
We have  previously shown  that  clonable B  cells emerge in  irradiated CBA/N  mice 
grafted with  normal  hematopoietic cells and  all of these were  of donor origin  (17). 
Monitoring the emergence and expansion of colony-forming B  cells in transplanted 
CBA/N  mice thus offers a  unique  model for assessing the differentiative and prolif- 
erative potential of B  lymphocyte precursors. 
Generation of B  Cells in Irradiated CBA/N Mice after Grafting.  The kinetics of B-cell 
emergence in irradiated homozygous CBA/N  recipients of 9-10 d  fetal yolk sac,  12- 
13 fetal liver, or adult bone marrow are compared in Fig.  1. Recipients of either fetal 
liver or  bone  marrow  had  easily detectable  numbers  of clonabte  B  cells in  spleen 
within 8  d  of grafting and these expanded to normal adult values within 4-6 wk. In 
contrast, CFU-B usually did not appear in recipients of yolk sac until after 9 wk and 
even  then  never approached  normal  levels. In all cases colony-forming B  cells were 
simultaneously detected in the bone marrow although  in lower frequency relative to 
total nucleated cells. Similar results were obtained using irradiated (CBA/N  ×  CBA/ 
H)F1  male  and  female  recipients.  To  assess  the  extent  of chimerism  achieved  in 
irradiated  CBA/N  recipients,  we  undertook  cytogenic  analysis  of various  hemato- 
poietic cell  lineages including:  in  vivo spleen  colony-forming units  (multipotential 
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TABLE  I 
Incidence of B-Cell Colonies in CBA/H-7"67"6 and CBA/N Mice of Different Ages 
Number of B-Cell Colonies* 
Age  Organ tested 
CBA/It-T6T6  CBA/N 
Incidence/ 
Incidence/10  r'  Total (x  10 a) per  10  r' cultured 
cultured cells:t:  organ  cells 
d 
-3  Spleen  1.7  0.002  0 
Liver  0.8  NIl  0 
3  Spleen  138.0  0.46  0 
I,iver  36.0  NIl  0 
7  Spleen  113.0  28.7  0 
I,iver  17.0  NIl  0 
56  Spleen  736.0  991.9  0 
BM  208.0  NIl  0 
LN  364.0  ND  0 
',365  Spleen  1,180.0  1,123.',3  0 
BM  185.0  NI)  0 
LN  442.0  NIl  0 
* Mean number of B-cell colonies determined from three-five replicate cuhures potentiated by LPS (10 
g/roll. 
:1: It has been previously determined (18) that the cloning efficiency  of slg  + B cells in newborn and adult 
tissues is similar when LPS is used to potentiate cultures. 
and  B  cells:  As  demonstrated  in  Table  II,  grafting  with  5  X  105  yolk  sac  cells 
consistently led  to  a  low  degree  of chimerism  in  which  donor  cells  were  equally 
represented  in each  of the  four cellular compartments tested.  In contrast,  grafting 
with  105  fetal  liver cells resulted  in variable degrees  of chimerism except  for  LPS- 
stimulated cells which always were predominantly  donor-derived. Grafting with larger 
numbers of fetal liver cells consistently resulted in nearly complete replacement of all 
compartments with donor cells. 
Generation of B  Cells in  Unirradiated CBA/N Mice after Grafting.  To further analyze 
the  development of CFU-B  from  a  potential precursor,  reconstitution experiments 
were performed utilizing unirradiated CBA/N mice. It has been previously demon- 
strated that reconstitution of unirradiated CBA/N mice with spleen cells from normal 
donors overcomes the B-cell defect  and, furthermore, results in chimerism restricted 
to the B  lineage (25, 26). We confirmed and extended this finding using the cloning 
assay  to  measure  the  reconstitution potential of normal cells  derived  from  various 
fetal and adult tissues. In preliminary experiments we established that injection of as 
few as  105 fetal liver cells led to small but variable numbers of clonable B cells 3 wk 
later, whereas  larger  numbers of cells led  to  reproducible levels of clonable B  cells 
after a  much shorter interval. Clonable B cells emerged in bone marrow and spleen 
of CBA/N  mice  12-15  d  after  grafting with  2.5  X  107  fetal  liver cells  and  were 
subsequently detected in lymph nodes as well (Fig. 2). 
Clonable B  cells were also  detected  in unirradiated CBA/N mice grafted  with  5 
X  107 bone marrow cells, although lower numbers of CFU-B were generated. This 
finding was confirmed in other experiments in which numbers of clonable B cells in 
spleens of fetal liver recipients were 2- to 4-fold higher than in recipients of twice as 552  B  LYMPHOCYTE  PRECURSORS 
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Flo.  I.  Kinetics of colony-forming B-cell generation  in irradiated CBA/N mice grafted with 5  X 
104 bone marrow (11),  105  12- to  13-d  fetal liver (O), or 5  X  10  ~ to 2  ×  106 9- to  10-d yolk sac tO) 
from CBA/H-T6T6 donors. Recipient mice were exposed either to 1,000-1,050  rods (single dose) or 
to  1,300  rads  (split  dose)  1  h  before  cell  transfer.  The  number  of cells  injected  were  based  on 
preliminary experiments which revealed  that the mean CFU-s  level  in  12-15  irradiated recipients 
of aduh bone marrow,  12- to  13-d fetal liver, or 9- to  10-d  yolk sac was 11.2/105,  4.5/10 s, and 1.3/ 
10 ~, respectively. 
TABLE  II 
Cytogenetic Analysis of Grafted CBA/N Mice* 
No. and origin 
Recipient  of donor ce(ts:~ 
No ofT6/total  ai~d 'Z donor 0ange) 
Grantdo~yte-macro-  T  Ivmphoblastsl]  B lymphublasts]J  Spleen colonies§  phage colonicsll  ' 
Irradiated  5  ×  10" FI,  27/28 96(93.100)  276/300 92(Bg--lg0)  332/362 92(88  97)  398/400 99(98  10~) 
CBA/N  l0  s FI,  9/17 53(0.100)  39/65  60(38.100)  24/64  40(30  75)  107/I 13 95(85  100) 
5  x  105YS  2/18  II  26/211  12(2-17)  18/137  13(10  16)  28/168  17(9  25) 
Unh'radiatcd  50  X  10~BM  2/31  6(0  33)  46/601)  8(I  13)  31/1~00  3[3  8)  127/60021(12  33) 
CBA/N  25  x  10  ~ FI,  0/40  l)  20/405  5(I-8)  55/658  8(3/18)  351/600 59(31  79) 
* Expclimcntal  details describt:d in Materials and Methods. 
:~ Cells derived fi'om cithel  12- to  13-d f~'tal liver,  10-d yolk sac, or aduh bol+e mallow. Data presented was pooled from results obtained with 
three  five individual n~ice assayed fol each group 
§ Spleen colonies were obtained  from the spleen of heavily irradiated secondary recipients 9-10 d  after grafting with 2.5  X  104 bone marr'ow 
cells fi'om CBA/N  primary recipients  10  50 Individual  metaphascs were scored to detclmine the chromosome type of each spleen cotuny. 
[] Cell stimtdatcd as described in Materials and Methods. 
much  bone  marrow  cells  14-16  wk after transplantation.  In contrast  to the generalized 
chimerism  of  hematopoietic  tissues  after  grafting  of  irradiated  mice,  significant 
numbers  of  donor  cells  were  only  found  among  B  cells  in  unirradiated,  grafted 
CBA/N  mice  (Table  II). PAIGE,  KINCADE,  MOORE,  AND  LEE  553 
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FIe.  2.  Kinetics of colony-forming B-cell generation in unirradiated CBA/N mice grafted with 2.5 
X  107  14-d fetal  liver (a), 5  ×  [07 spleen (b), 3  ×  107 lymph node (c), or 5  X  107 bone marrow (d) 
from CBA/H donors. Clonable cells were measured in the bone marrow (O), spleen (0), and lymph 
node  (A)  of recipient  mice.  Each  point  represents the  mean of 3-4  replicate  cultures  from 2-3 
individual mice reported as the percentage of normal control cells plated at the same time. Control 
values (expressed as colonies/10" cultured cells)  for the individual time points were: spleen, 319  __. 
13, 878  _  76,  1,058 +  48, 518  __.  35, 570  _  30, 688  ±  32, 611  +  35, and 893  ±  36;  lymph node, 
128  ±  17,247  ±  63, 380  +  10,87  ±  12, 265  +  4, 248  ±  17,238  ±  18, and  102  ±  18; and bone 
marrow, 278  ±  40,  312  ±  16, 284  ±  21,419  ±  19, 445  ±  16, 265  ±  25,  180  ±  2, and 273  ±  8. 
Transferred  lymph node cells were inefficient  in achieving B-cell chimerism of any 
of the recipient  tissues.  Recipients of 5  ×  107 spleen cells had substantial  numbers of 
clonable B cells in spleen and lymph nodes but the degree of chimerism obtained  18 
h  after grafting was essentially unchanged over a  40-d period. 
Contribution  of sIg  + B  Cells to B-Cell Generation.  Donor cell suspensions transferred in 
the above experiments are heterogenous in their content of B cells and their progen- 
itors.  This  is  particularly  evident  in  bone  marrow  where  both  mature  B  cells  and 
cIg+sIg  -  cells, which are assumed to be the immediate precursors of sIg  + B  lympho- 
cytes,  are  frequent.  The  importance  of sIg  +  cells  in  the  transferred  bone  marrow 
suspensions was assessed in two ways. Fig. 3 shows the results of experiments in which 
CBA/N  mice were grafted with bone marrow derived  from either untreated  control 
CBA/H-T6T6  mice or from CBA/H-T6T6  mice treated with anti-~ antibodies  from 
birth.  In  1-mo-old mice  treated  in  this  manner,  sIg  ÷  cells  were  reduced  by 95%  in 554  B LYMPIlOCYTE  PRECURSORS 
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FIG. 3.  Emergence ofclonable B cells in irradiated (1,050 rads) (circles) or unirradiated (squares) 
CBA/N recipients of CBA/H-T6T6 bone marrow derived from normal (O, I-l) or anti-# suppressed, 
B-cell depleted (0, I) donor mice. Each point represents the mean of 3-4 replicate spleen cultures 
from 2 3 individual mice. Unirradiated  mice were injected with 2.5  X  107 bone marrow cells. 
Irradiated mice were injected with 2.5 X 10  ~ bone marrow cells. 
spleen and 83%  in bone marrow while clonable B cells were reduced by 99, 98, and 
91%  in  spleen,  lymph  node  and  bone  marrow,  respectively.  Such  B-cell  deficient 
marrow  was  equivalent  to  normal  marrow  in  generation  of  clonable  B  cells  in 
irradiated recipients and produced almost as many functional B cells after transfer to 
unirradiated CBA/N mice (Fig. 3). 
An  additional procedure,  in which  bone marrow  was  incubated on  Petri  dishes 
coated with anti-IgM antibodies, was also utilized to remove B cells. Like the previous 
experiment, CFU-B  generation in  unirradiated recipients of depleted  marrow  was 
similar to that in recipients of normal marrow, as demonstrated in Table III. 
Contribution  of Stem  Cells  to  B-Cell Generation.  Bone marrow and fetal liver contain 
multipotential stem  cells  as  well  as  pre-B  cells  and  it  is  not  clear  which  of these 
populations are primarily responsible for B-cell generation in recipient mice. Because 
pre-B cells have not been detected in yolk sac, the results of experiments illustrated in 
Fig.  2, in which equal numbers of stem cells were  injected from either fetal liver or 
yolk sac, suggest that pre-B cells are the major source of subsequent B-cell generation. 
An alternative explanation is that stem cells in yolk sac and other sites are intrinsically 
different and, therefore, a  second protocol, illustrated in Fig. 4,  was used to  further 
assess  stem  cell  contribution. We  injected a  mixture of CBA/N  and  chromosome- 
marked CBA/H-T6T6 bone marrow (50:50)  into an irradiated CBA/N host. 8-14 d 
later, the resultant spleen loci, which are the clonal progeny of stem cells undergoing 
self-renewal and differentiation, were individually processed  for cytogenetic analysis 
and assayed for colony-forming  B cells. If the colony-forming B cells were the progeny PAIGE,  KINCADE,  MOORE,  AND LEE  555 
TABLE III 
Colony-forming B Cells in Unirradiated CBA/N Mice Reconstituted with Normal or B-Cell Depleted 
CBA/H- T6T6 Bone Marrow 
Potentiator used§  Organ tested 
No. of B-cell colonies in CBA/N mice reconstituted 
with:* 
Normal bone marrow  B-cell depleted marrow 
Incidence/106 cultured cells~ 
LPS  Spleen  814 ~  1.17  703 _:  1.43 
Lymph node  177 +X  1.68  161  +X  1.65 
Bone marrow  91  X+  1.18  71  X..  1.50 
LPS  Spleen  1,086 +X  1.09  1,060 +X  1.29 
+  Lymph node  579 X+  1.29  541  +X  1.30 
SRBC  Bone marrow  236 +X  1.12  198 +X  1.40 
* Unirradiated CBA/N mice were reconstituted  with 5  Y  10  7 CBA/H-T6T6 bone marrow cells. B-cell 
depleted marrow contained <0.5% slg  ÷ cells compared to 10% sIg  + cells in control marrow. 
:~ Geometric mean of the incidence of colony-forming B cells in three replicate cultures from four individual 
recipients assayed  4.5-9 mo after reconstitution. A two-sample t test  revealed no significant difference 
between recipients of normal or B-ceil depleted marrow (P >  0.8 in all cases). 
§ Cultures were potentiated by LPS (10/xg/ml)  +  washed SRBC (1%). 
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Protocol utilized to determine relative stem cell contribution to the emergence of clonable 
of donor stem cells, a  proportion  of the spleen foci derived from the normal CBA/H- 
T6T6  stem  cells should  contain  colony-forming  B  cells.  In  contrast,  the  T6-  spleen 
foci,  derived  from  the  CBA/N  stem  cells,  should  be  uniformly  negative  for colony- 
forming B  cells. As depicted  in  Table  IV, 81  individual spleen  foci derived from the 
50:50  mixture  were  analyzed  for  CFU-B  and  22  of  these  were  also  processed  for 
chromosome  typing.  As  expected,  of those  typed,  approximately  one-half were  T6- 
derived,  whereas  the  rest,  lacking  the  T6  marker,  were  derived  from  CBA/N  stem 556  B LYMPttOCYTE  PRECURSORS 
TABLE  IV 
Colony-forming B Cells in Spleen Foci of Irradiated CBA/N Mice Given a Mixture  of CBA/H-T6T6 and 
CBA/N Bone Marrow 
Clonable B cell/10  '~ spleen  No. of foci positive 
for CFU-B/total  Percentage posi-  colony cells:~ 
Origin of spleen loci*  No. of foci exam-  tive 
Arithmetic  ined  SEM  mean 
% 
CBA/H-T6T6  8/9  89  4.9  1.5 
CBA/N  12/13  92  3.4  1.3 
Untyped  54/59  92  3.4  1.2 
Total  74/81  91  3.3  1.1 
* Spleen loci were obtained 8-14 d afler grafting irradiated (1,050 rads) CBA/N mice with 2.5-5  X  104 of 
an equal parts mixture of CBA/H-T6T6 and CBA/N bone marrow cells. 
:~ B-cell colonies were potentiated by LPS (10 #g/ml) and SRBC (1%). Geometric means of the incidence 
of B-cell colonies in positive foci are presented. As determined  using a two-sample t test, the difference 
between CBA/tt-T6T6 foci and CBA/N foci was not significant (P =  0.2). 
cells. However, 90% of all spleen foci, regardless of origin, contained colony-forming 
B  cells. Furthermore,  there was  no significant difference in the incidence of CFU-B 
found  in spleen colonies of different origin although  intercolony areas contained  ~5 
times as many  CFU-B  (24.5  CFU-B/105  intercolony cells). Thus,  we conclude that 
CBA/H-T6T6-derived pre-B cells present in the inoculum randomly seeded through- 
out the host spleen, expanded contiguously with stem cells, and were incorporated in 
the  developing splenic foci. To  exclude the unlikely possibility that  the  mixture of 
CBA/N  and  CBA/H-T6T6  cells conferred  colony-forming ability on  CBA/N  cells, 
we recovered  B-cell colonies grown  from  whole spleen  reconstituted with  the  50:50 
mixture and found that  126/126 of these were T6T6. 
To  ensure  that  our  results  would  be  comparable  to  the  observations  of another 
group  (27,  28), we performed additional experiments with a  slightly modified exper- 
imental  design. This  included the  use of CBA/H  recipients instead of CBA/N  and 
the use of SRBC  instead of SRBC  +  LPS  to stimulate CFU-B  formation.  In  these 
experiments,  100%  of  the  injected  cells  were  normal  CBA/H-T6T6.  The  results, 
shown  in Table V, indicate:  (a)  that 90% of all spleen foci in either recipient contain 
CFU-B;  (b)  that  intercolony areas  always contained  more  CFU-B  than  did  spleen 
foci; and  (c)  that  unlike CBA/N  recipients, normal  irradiated uninjected mice have 
background  levels of CFU-B.  These  colonies  were  morphologically  lymphoid  and 
inhibited by anti-in antibodies. 
Discussion 
A  major goal of these studies was  to compare the differentiative and  proliferative 
potential  of  various  B-lymphocyte  precursors.  To  accomplish  this  we  utilized  an 
adoptive transfer assay in which  the emergence of B  lymphocytes was  monitored in 
CBA/N  mice reconstituted with  fetal or adult sources of B-cell progenitors derived 
from CBA/H-T6T6  donors. We determined that  injection of small numbers of 12-d 
fetal  liver  or  adult  bone  marrow  cells  into  irradiated  CBA/N  recipients  led  to 
detectable  numbers  of CFU-B  within  8  d  and  normal  levels within  4-6  wk.  The 
kinetics of B-cell recovery are similar to other studies in which functional or nonfunc- PAIGE,  KINCADE,  MOORE,  AND  LEE  557 
TABLE  V 
Distribution of CIonable B Cells within and between Splenic Foci of Irradiated CBA/H- T6T6 or CBA/N 
Mice Given CBA/H-T6T6 Bone Marrow 
Host  Agar culture stimulant 
No. positive/total 
No. examined 
Clonable B cells/10  's cul- 
tured cells§ 
Unin-  Inter-  Inter- 
jected  Foci  colony  Foci  colony  spleen u 
CBA/H-T6T6  SRBC  18/19  5/5  1.3  4.4  3.0 
SRBC +  LPS  19/19  5/5  5.2  13.4  8.9 
CBA/N  SRBC  17/21  8/9  1.1  3.4  0 
SRBC +  LPS  19/21  10/10  3.1  21.5  0 
* CBA/H-T6T6 or CBA/N mice were exposed  to 1,050 rads  1 h before grafting with 2.5  x  l04 CBA/H- 
T6T6 bone marrow cells. 
:~ B-cell colonies within splenic  foci or in intercolony areas measured  12 d after reconstitution. Data from 
five individual mice were pooled for each group.  Mean number of CFU-s in CBA/H-T6T6 recipients  was 
4.5/spleen, and in CBA/N recipients,  5.0/spleen. 
§ Geometric mean  of the incidence of B-cell colonies  in  the positive loci  or intercolony areas.  Within 
individual spleens the incidence of B-cell colonies within foci differed significantly from the incidence of 
B-cell colonies in intercolony areas (P <  0.01 using a paired t test). B-cell colonies were potentiated with 
1% SRBC ±  LPS (10/tg/ml). 
II Geometric  mean  of the  incidence of splenic  B-cell  colonies  of six  irradiated  mice which  were  not 
reconstituted with donor cells. 
tional assays  were used  to  follow B-cell regeneration  from fetal liver or bone marrow 
(8,  29-33).  Because  fetal  liver of the age used  in  this  and  previous studies  contained 
no sIg  + cells, these experiments clearly indicate that the transition  from sIg- precursor 
cells  to  sIg  +  cells  occurs  in  recipient  mice.  Extending  this  analysis  to  adult  bone 
marrow sIg- cells, CBA/H-T6T6  donors were treated  from birth with anti-~t antibod- 
ies,  a  procedure  which  greatly  reduces  sIg  ÷  cells  but  does  not  alter  the  number  of 
cIg+sIg  -  pre-B  cells  (15).  When  the  reconstitution  potential  of bone  marrow  from 
mice treated  in this manner  was compared  to bone marrow  from normal controls, no 
difference in CFU-B  generation was found, indicating that donor sIg  + cells contribute 
little if anything to subsequent  CFU-B  formation. A  similar result was obtained using 
a  second  procedure  in  which  B  ceils  were  depleted  by  incubation  in  Petri  dishes 
previously coated with anti-IgM  antibodies.  These data  thus document  the extensive 
proliferation of sIg- B-cell precursors. 
Because  the  role  of  pluripotent  stem  cells  in  these  reconstitution  experiments 
remains  speculative, we critically examined  their contribution  in our system.  In one 
approach,  irradiated  CBA/N  mice were reconstituted  with stem cells derived from 9- 
to  10-d  fetal  yolk  sac  as  no  cells  with  characteristics  of the  B  lineage  have  been 
detected  in this site, even after extensive organ  culture  (12,  34).  For comparison,  we 
injected control mice with  12- to  13-d fetal liver, a  source of both stem cells and  pre- 
B  cells, and  adjusted  the cell numbers  so that  approximately  equal  numbers  of stem 
cells were injected from either source. The inability of yolk sac cells to rapidly generate 
CFU-B  in the host CBA/N  mice, in contrast  to fetal liver which lead to high levels of 
clonable  B  cells in  <2  wk, suggests  that  pre-B  cells and  not  stem  cells are  primarily 
responsible  for B-cell reconstitution.  This interpretation  is supported  by chromosome 
analysis  of CBA/N  mice  after  long-term  reconstitution  with  either yolk sac  or  fetal 
liver. Yolk sac cells lead to approximately  equal representation  of donor cells in each 558  B LYMPHOCYTE PRECURSORS 
of the cellular compartments we examined, usually about  15% donor and 85%  host. 
Fetal liver, however, was more variable, always leading to >90% donor in the B-cell 
compartment whereas other compartments ranged from 0-100%. These data reflect 
the  efficiency  of pre-B  to  B-cell  transition  in  fetal  liver  grafts  and,  furthermore, 
support  the  contention that  significant  competition exists  between  donor and  host 
cells even after lethal irradiation  (35). 
An alternative explanation  for these data is that stem cells  in yolk sac may differ 
from stem  cells  in  other  locations in  their  ability  to  generate  B  cells.  Therefore,  a 
second method was  devised  to  determine  the  efficiency of the  stem  cell  to CFU-B 
transition  using adult  bone marrow-derived stem cells.  A  50:50 mixture of CBA/N 
and CBA/H-T6T6 was injected  into an  irradiated  mouse and  the resultant  splenic 
foci, each of which is primarily composed of the clonal progeny of a  hematopoietic 
stem cell  undergoing self-renewal  and differentiation,  were assayed for CFU-B and 
typed for the presence of the T6 chromosome marker.  As predicted,  approximately 
one-half of the spleen  foci were derived from CBA/H-T6T6 stem cells  whereas  the 
rest  came from CBA/N stem  cells.  However, >90% of all  spleen  foci, regardless  of 
origin, contained clonable B cells.  This indicates that CBA/N spleen foci contained 
CBA/H-T6T6 B cells.  To ensure that  these were not in  fact CBA/N B cells  which 
had  somehow acquired  the  ability  to  form colonies  in  soft  agar  as  a  result  of the 
exposure to normal bone marrow, we chromosome typed the CFU-B from the spleens 
of mice injected with  the  50:50 mixture and  found that  100% of these were T6T6. 
Because the clonable B cells found within spleen foci derived from CBA/N stem cells 
were not of CBA/N origin, they must have been derived either from T6T6 pre-B cells 
present  in  the  original  inoculum  or,  alternatively,  have  migrated  from  the  T6T6 
spleen  foci  where  the  transition  from  stem  cell  to  B  cell  could  have  occurred.  If 
migration between spleen foci was significant, it could be argued that the number of 
foci positive for CFU-B should increase with  time and,  furthermore, that  those foci 
producing colony-forming B cells might contain more of these than those foci positive 
as  a  result  of migration.  Our  data  refute  both  of these  predictions  as  the  same 
percentage of foci are positive at  8 d  after injection as are positive at  14 d,  and  no 
significant difference in the number of CFU-B was found in foci derived from either 
CBA/H-T6T6 or CBA/N stem cells.  These data suggest, therefore,  that  pre-B cells 
present  in  the  inoculum  randomly  seeded  throughout  the  spleen  and  that  those 
expanding  contiguous  with  hematopoietic  stem  cells  were  incorporated  into  the 
developing splenic foci. The finding that interfoci areas contained a higher incidence 
of CFU-B than was found within foci is consistent with this view, as these would not 
be  diluted  by  the  expanding  number  of nonlymphoid  hematopoietic  cells  found 
within splenic foci. Whereas these data do not prove that stem cells  are incapable of 
differentiating into B cells within splenic foci, they do imply that this transition, if it 
occurs,  is  not  of the  same  magnitude as  the  pre-B  to  B-cell transition  and  thus  is 
obscured. 
This conclusion contrasts with the results of a similar investigation (27, 28). Because 
slightly different procedures were used we repeated our experiments using conditions 
which more closely approximated the other study. This included using CBA/H mice 
as  recipients  rather  than  CBA/N and  the  use of SRBC alone to stimulate  colony- 
forming B cells  rather than  SRBC  +  LPS. With these modifications we still  found 
that >90% of the splenic foci were positive with more CFU-B present  in the interfoci PAIGE, K1NCADE, MOORE, AND LEE  559 
areas than within  foci.  In contrast, Lala and Johnson (28)  reported that only ~40% 
of spleen  foci contained  clonable  B  cells  and  more were  detected  within  foci than 
between  them.  In addition,  the chromosome type of the CFU-B detected  matched 
that of the spleen colony from which they were derived, although in  14 of 19 cases 
this  claim  was  based  on  five  or  fewer  CFU-B  metaphases  scored.  In  our  study, 
chromosome analysis  of CFU-B  generated  from  the  50:50  mixture  of CBA/N  + 
CBA/H-T6T6 revealed that  100% (126/126) were T6T6. This protocol thus provides 
a  far more sensitive method for detecting contamination of spleen  foci by exogenous 
cells as we can demonstrate the presence of even one T6T6 CFU-B in an entire CBA/ 
N-derived spleen colony. In addition, our results are in agreement with several other 
studies  which demonstrate  that  spleen  colonies often contain a  small  percentage of 
ceils  not  derived  from the colony itself (1,  36).  It should also be noted that  CFU-B 
were  never  detected  in  spleen  colonies  derived  from  CBA/H-T6T6 yolk  sac  cells 
injected into irradiated CBA/N recipients. The yolk sac, in contrast to fetal liver and 
bone  marrow,  is  a  source of multipotential  stem  cells  in  which  Committed  B-cell 
progenitors have not been demonstrated.  As we have previously mentioned, normal 
CBA/H recipients subjected to even  1,350 rads still  possessed detectable numbers of 
clonable  B  cells  (although  no  CFU-s)  when  assayed  10-14  d  later.  This  result 
demonstrates the resiliency of endogenous hematopoietic precursors and emphasizes 
the  importance  of  using  background-free,  CBA/N  mice  for  these  reconstitution 
experiments.  It is essential to reiterate that our results do not disprove the possibility 
that stem cells  can differentiate into lymphocytes within splenic microenvironments. 
However, they strongly suggest that the methodology employed thus far is insufficient 
for this determination. 
To extend our analysis of B-cell  differentiation, we have also utilized unirradiated 
CBA/N mice as recipients of fetal and adult CBA/H-T6T6 cells. We found that rapid 
and  long-lasting engraftment  was achieved with either  fetal  or adult  donor cells  as 
monitored by colony formation. Furthermore, in contrast to reconstitution of irradi- 
ated  CBA/N recipients,  donor cells  were  largely  restricted  to  the  B  lineage.  These 
results thus support a previous study ofVolfet al. (26) which showed that unirradiated 
CBA/N mice can be reconstituted with adult spleen cells  resulting in chimerism only 
in the B-cell  compartment. Q uintans et al.  (37),  measuring responsiveness to PC and 
TNP antigens, have demonstrated that unirradiated (CBA/NxBALB/c)F1 c~ mice can 
be reconstituted with normal adult cells  but in their study neonatal liver was unable 
to colonize recipients unless these mice were first  exposed to a  low dose of radiation 
(32). As assessed  by the colony-forming B-cell assay in our study, fetal liver consistently 
led to the highest degree of reconstitution when compared to adult donor cells,  even 
bone marrow. This discrepancy in the grafting ability of bone marrow and fetal liver 
cells  was  only  apparent  when  unirradiated  recipients  were  used.  Because  B-cell 
depletion  experiments  demonstrated  that  sIg- pre-B  cells  account  for  most  of the 
observed  B-cell  reconstitution  from bone marrow, these  data may indicate  that  an 
intrinsic difference exists between fetal liver and bone marrow pre-B cells.  Estimates 
of the  number  of pre-B  cells  found  in  these  sites  make  this  difference  even  more 
remarkable.  For example, Burrows et al.  (15)  estimate that  3% of bone marrow cells 
are pre-B cells whereas similar methods reveal only 0.007-0.3% of 13-d fetal liver cells 
are pre-B cells  (15). Other methods result in even lower estimates (38).  Based on these 
figures, recipients of bone marrow receive  100-1,000 times more pre-B cells  than do 560  B LYMPHOCYTE PRECURSORS 
recipients of fetal liver. Among the possible explanations for this difference are:  (a) 
Pre-B cells in fetal liver have a much higher proliferative potential than bone marrow 
pre-B cells; (b) estimates of pre-B cells by cytoplasmic fluorescence may not accurately 
reflect the actual number of B-cell progenitors; and  (c) the majority of adult  pre-B 
cells are rejected by the CBA/N recipient by a mechanism which does not affect fetal 
cells. 
The  rationale  for  utilizing  CBA/N  mice  for  these  experiments  was  to  provide 
suitable  environments  for  expansion  and  differentiation  of stem  cells  and  other 
precursors which were both functionally and cytogenetically marked. This was highly 
successful and all of our observations suggest that this process occurs as efficiently in 
irradiated CBA/N mice as in irradiated normal mice. Incidental to these studies were 
observations which help to delineate the selective humoral immunodeficiency of these 
mice. Firstly, the finding that  yolk sac cells produced functional B cells in CBA/N 
recipients  provides  strong  evidence  that  inductive  microenvironments  for  B-cell 
development are intact in CBA/N mice. All previous grafting experiments with these 
mice employed donor cell suspensions which contained precommitted cells. Certain 
of our findings also address the question of which stage of development the mutant 
gene product is normally expressed. It has previously been suggested that the defect 
might occur relatively late in development such that certain immature functional cells 
are spared (25, 39, 40). The finding that normal but not CBA/N fetal liver contains 
clonable cells by 17 d of gestation is not consistent with this idea. Success in grafting 
hemopoietically deficient but not normal mice without prior irradiation indicates that 
you may only be able to engraft with cell types that  are deficient in the recipient. 
According to  this  perhaps  oversimplified logic, CBA/N  mice must  be  particularly 
deficient in a category of pre-B cell which is prevalent in early fetal liver. Our results, 
therefore, support  an alternate hypothesis that  multiple  lineages of B  cells diverge 
early in development to yield functionally restricted progeny (41). 
In summary, the demonstration that yolk sac cells are capable of developing into 
colony-forming B cells in irradiated CBA/N recipients confirms the pluripotentiality 
of these cells. Nonetheless, the finding that pluripotent stem cell contribution to B-cell 
development, though  possible,  is  minimal  in  our systems raises  the  possibility that 
steady-state adult  lymphopoiesis does not  significantly involve multipotential  stem 
cells.  Furthermore, the results obtained  from in  vivo transfer experiments utilizing 
unirradiated recipients suggest a previously undetected degree of heterogeneity in the 
pre-B compartment and imply that lymphopoietic processes may differ significantly 
in adult and fetal life. 
Summary 
The relative ability of various precursors to generate functional B cells in vivo was 
assessed by transferring normal, chromosomally-marked CBA/H-T6T6 cells to irra- 
diated or unirradiated immunodeficient CBA/N mice. Emergence of donor-derived 
B cells was monitored by means of a B-cell cloning assay (in which CBA/N cells are 
inactive), and by karyotypic analysis of lymphoid, myeloid, and stem cell metaphases. 
Grafts of lymph node, spleen, anti-# surface immunoglobin suppressed bone marrow, 
sIg  + cell-depleted marrow, normal marrow, fetal liver, and yolk sac suggest:  (a) there 
is  little  self-renewal  of sIg  +  B  cells  in  these  models;  (b)  pre-committed  cells  have 
extensive proliferative/differentiative potential and at least initially contribute most PAIGE,  KINCADE, MOORE,  AND LEE  561 
of the  newly-formed  B  cells;  (c)  populations  or  pre-B  cells obtained  from  various 
sources differ in their regenerative ability; (d) CBA/N  mice are deficient in a category 
of pre-B cells which are found in fetal liver; and  (e) selective B-cell chimerism results 
from grafting of unirradiated CBA/N  mice. 
Received for publication  March 26 1979. 
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